Oaktree Acquisition Corp. III Life Sciences (OACC) reporting calendar
Oaktree Acquisition Corp. III Life Sciences files periodic reports with the SEC as OACC on Nasdaq. Atlas tracks 6 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 23 Jul 2026 – 3 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 13 May 2026
- Reports on record
- 6
How this window is derived. Derived from this issuer's own filing history: 6 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open OACC market profile
Latest filing on SEC EDGAR ↗
Blank Checks reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 13 May 2026 | 43 days | 0001193125-26-221814 |
| 10-K | 31 Dec 2025 | 26 Mar 2026 | 85 days | 0001193125-26-126536 |
| 10-Q | 30 Sep 2025 | 13 Nov 2025 | 44 days | 0001193125-25-280296 |
| 10-Q | 30 Jun 2025 | 12 Aug 2025 | 43 days | 0001193125-25-178570 |
| 10-Q | 31 Mar 2025 | 14 May 2025 | 44 days | 0001193125-25-119885 |
| 10-K | 31 Dec 2024 | 27 Mar 2025 | 86 days | 0001193125-25-065546 |
Source: SEC EDGAR company submissions for CIK 0002029769. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.